Found 34 Enz. Inhib. hit(s) with all data for entry = 7134 
Affinity DataIC50: 1.90nMpH: 7.4Assay Description:A biotin labeled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2) S...More data for this Ligand-Target Pair
Affinity DataIC50: 2.10nMpH: 7.4Assay Description:A biotin labeled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2) S...More data for this Ligand-Target Pair
Affinity DataIC50: 2.20nMpH: 7.4Assay Description:A biotin labeled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2) S...More data for this Ligand-Target Pair
Affinity DataIC50: 2.20nMpH: 7.4Assay Description:A biotin labeled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2) S...More data for this Ligand-Target Pair
Affinity DataIC50: 2.70nMpH: 7.4Assay Description:A biotin labeled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2) S...More data for this Ligand-Target Pair
Affinity DataIC50: 3.60nMpH: 7.4Assay Description:A biotin labeled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2) S...More data for this Ligand-Target Pair
Affinity DataIC50: 3.60nMpH: 7.4Assay Description:A biotin labeled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2) S...More data for this Ligand-Target Pair
Affinity DataIC50: 3.60nMpH: 7.4Assay Description:A biotin labeled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2) S...More data for this Ligand-Target Pair
Affinity DataIC50: 5.20nMpH: 7.4Assay Description:A biotin labeled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2) S...More data for this Ligand-Target Pair
Affinity DataIC50: 5.60nMpH: 7.4Assay Description:A biotin labeled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2) S...More data for this Ligand-Target Pair
Affinity DataIC50: 7.10nMpH: 7.4Assay Description:A biotin labeled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2) S...More data for this Ligand-Target Pair
Affinity DataIC50: 7.20nMpH: 7.4Assay Description:A biotin labeled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2) S...More data for this Ligand-Target Pair
Affinity DataIC50: 9.40nMpH: 7.4Assay Description:A biotin labeled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2) S...More data for this Ligand-Target Pair
TargetIsoform 2 of Vascular endothelial growth factor receptor 3 (Short) 98-1298](Homo sapiens (Human))
Cancer Therapeutics Crc
US Patent
Cancer Therapeutics Crc
US Patent
Affinity DataIC50: 205nMpH: 7.4Assay Description:Compounds of the invention may be tested for in vitro activity in the following assay: A biotin labeled peptide is used as substrate (amino acid sequ...More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 3 [818-948,1003-1077](Homo sapiens (Human))
Cancer Therapeutics Crc
US Patent
Cancer Therapeutics Crc
US Patent
Affinity DataIC50: 240nMpH: 7.4Assay Description:Compounds of the invention may be tested for in vitro activity in the following assay: A biotin labeled peptide is used as substrate (amino acid sequ...More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 3 [818-948,1003-1077](Homo sapiens (Human))
Cancer Therapeutics Crc
US Patent
Cancer Therapeutics Crc
US Patent
Affinity DataIC50: 275nMpH: 7.4Assay Description:Compounds of the invention may be tested for in vitro activity in the following assay: A biotin labeled peptide is used as substrate (amino acid sequ...More data for this Ligand-Target Pair
TargetIsoform 2 of Vascular endothelial growth factor receptor 3 (Short) 98-1298](Homo sapiens (Human))
Cancer Therapeutics Crc
US Patent
Cancer Therapeutics Crc
US Patent
Affinity DataIC50: 538nMpH: 7.4Assay Description:Compounds of the invention may be tested for in vitro activity in the following assay: A biotin labeled peptide is used as substrate (amino acid sequ...More data for this Ligand-Target Pair
TargetIsoform 2 of Vascular endothelial growth factor receptor 3 (Short) 98-1298](Homo sapiens (Human))
Cancer Therapeutics Crc
US Patent
Cancer Therapeutics Crc
US Patent
Affinity DataIC50: 1.01E+3nMpH: 7.4Assay Description:Compounds of the invention may be tested for in vitro activity in the following assay: A biotin labeled peptide is used as substrate (amino acid sequ...More data for this Ligand-Target Pair
TargetIsoform 2 of Vascular endothelial growth factor receptor 3 (Short) 98-1298](Homo sapiens (Human))
Cancer Therapeutics Crc
US Patent
Cancer Therapeutics Crc
US Patent
Affinity DataIC50: 1.18E+3nMpH: 7.4Assay Description:Compounds of the invention may be tested for in vitro activity in the following assay: A biotin labeled peptide is used as substrate (amino acid sequ...More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 3 [818-948,1003-1077](Homo sapiens (Human))
Cancer Therapeutics Crc
US Patent
Cancer Therapeutics Crc
US Patent
Affinity DataIC50: 3.69E+3nMpH: 7.4Assay Description:Compounds of the invention may be tested for in vitro activity in the following assay: A biotin labeled peptide is used as substrate (amino acid sequ...More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 3 [818-948,1003-1077](Homo sapiens (Human))
Cancer Therapeutics Crc
US Patent
Cancer Therapeutics Crc
US Patent
Affinity DataIC50: 5.75E+3nMpH: 7.4Assay Description:Compounds of the invention may be tested for in vitro activity in the following assay: A biotin labeled peptide is used as substrate (amino acid sequ...More data for this Ligand-Target Pair
TargetIsoform 2 of Vascular endothelial growth factor receptor 3 (Short) 98-1298](Homo sapiens (Human))
Cancer Therapeutics Crc
US Patent
Cancer Therapeutics Crc
US Patent
Affinity DataIC50: 1.04E+4nMpH: 7.4Assay Description:Compounds of the invention may be tested for in vitro activity in the following assay: A biotin labeled peptide is used as substrate (amino acid sequ...More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 3 [818-948,1003-1077](Homo sapiens (Human))
Cancer Therapeutics Crc
US Patent
Cancer Therapeutics Crc
US Patent
Affinity DataIC50: 1.33E+4nMpH: 7.4Assay Description:Compounds of the invention may be tested for in vitro activity in the following assay: A biotin labeled peptide is used as substrate (amino acid sequ...More data for this Ligand-Target Pair
TargetIsoform 2 of Vascular endothelial growth factor receptor 3 (Short) 98-1298](Homo sapiens (Human))
Cancer Therapeutics Crc
US Patent
Cancer Therapeutics Crc
US Patent
Affinity DataIC50: 5.98E+4nMpH: 7.4Assay Description:Compounds of the invention may be tested for in vitro activity in the following assay: A biotin labeled peptide is used as substrate (amino acid sequ...More data for this Ligand-Target Pair
TargetIsoform 2 of Vascular endothelial growth factor receptor 3 (Short) 98-1298](Homo sapiens (Human))
Cancer Therapeutics Crc
US Patent
Cancer Therapeutics Crc
US Patent
Affinity DataIC50: >6.60E+4nMpH: 7.4Assay Description:Compounds of the invention may be tested for in vitro activity in the following assay: A biotin labeled peptide is used as substrate (amino acid sequ...More data for this Ligand-Target Pair
Affinity DataKd: 2.90nMpH: 7.4Assay Description:In running buffer (0.01 M HEPES pH 7.4, 0.15 M NaCl, 0.005% Surfactant P20, mM MgCl2, and 1% DMSO)N-terminally GST-fused purified FAK enzyme was capt...More data for this Ligand-Target Pair
Affinity DataKd: 0.810nMpH: 7.4Assay Description:In running buffer (0.01 M HEPES pH 7.4, 0.15 M NaCl, 0.005% Surfactant P20, mM MgCl2, and 1% DMSO)N-terminally GST-fused purified FAK enzyme was capt...More data for this Ligand-Target Pair
Affinity DataKd: 1.5nMpH: 7.4Assay Description:In running buffer (0.01 M HEPES pH 7.4, 0.15 M NaCl, 0.005% Surfactant P20, mM MgCl2, and 1% DMSO)N-terminally GST-fused purified FAK enzyme was capt...More data for this Ligand-Target Pair
Affinity DataKd: 0.790nMpH: 7.4Assay Description:In running buffer (0.01 M HEPES pH 7.4, 0.15 M NaCl, 0.005% Surfactant P20, mM MgCl2, and 1% DMSO)N-terminally GST-fused purified FAK enzyme was capt...More data for this Ligand-Target Pair
Affinity DataKd: 1.5nMpH: 7.4Assay Description:In running buffer (0.01 M HEPES pH 7.4, 0.15 M NaCl, 0.005% Surfactant P20, mM MgCl2, and 1% DMSO)N-terminally GST-fused purified FAK enzyme was capt...More data for this Ligand-Target Pair
Affinity DataKd: 0.740nMpH: 7.4Assay Description:In running buffer (0.01 M HEPES pH 7.4, 0.15 M NaCl, 0.005% Surfactant P20, mM MgCl2, and 1% DMSO)N-terminally GST-fused purified FAK enzyme was capt...More data for this Ligand-Target Pair
Affinity DataKd: 0.290nMpH: 7.4Assay Description:In running buffer (0.01 M HEPES pH 7.4, 0.15 M NaCl, 0.005% Surfactant P20, mM MgCl2, and 1% DMSO)N-terminally GST-fused purified FAK enzyme was capt...More data for this Ligand-Target Pair
Affinity DataKd: 1.70nMpH: 7.4Assay Description:In running buffer (0.01 M HEPES pH 7.4, 0.15 M NaCl, 0.005% Surfactant P20, mM MgCl2, and 1% DMSO)N-terminally GST-fused purified FAK enzyme was capt...More data for this Ligand-Target Pair
Affinity DataKd: 0.210nMpH: 7.4Assay Description:In running buffer (0.01 M HEPES pH 7.4, 0.15 M NaCl, 0.005% Surfactant P20, mM MgCl2, and 1% DMSO)N-terminally GST-fused purified FAK enzyme was capt...More data for this Ligand-Target Pair
